These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9500873)

  • 1. Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells.
    Ohlstein EH; Arleth AJ; Storer B; Romanic AM
    J Mol Cell Cardiol; 1998 Jan; 30(1):167-73. PubMed ID: 9500873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway.
    Romeo F; Li D; Shi M; Mehta JL
    Cardiovasc Res; 2000 Feb; 45(3):788-94. PubMed ID: 10728402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture.
    Saijonmaa O; Metsärinne K; Fyhrquist F
    Blood Press; 1997 Jan; 6(1):24-8. PubMed ID: 9116922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
    J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol inhibits vascular smooth muscle cell proliferation.
    Sung CP; Arleth AJ; Ohlstein EH
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):221-7. PubMed ID: 7679155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.
    Yue TL; Wang X; Gu JL; Ruffolo RR; Feuerstein GZ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1442-9. PubMed ID: 7791119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils.
    Yue TL; McKenna PJ; Gu JL; Cheng HY; Ruffolo RE; Feuerstein GZ
    Cardiovasc Res; 1994 Mar; 28(3):400-6. PubMed ID: 7909721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats.
    Fu GS; Huang H; Chen F; Wang HP; Qian LB; Ke XY; Xia Q
    Eur J Pharmacol; 2007 Jul; 567(3):223-30. PubMed ID: 17559835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
    Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of carvedilol, a new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery.
    Hattori Y; Nakaya H; Endou M; Nakao Y; Kanno M
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):572-9. PubMed ID: 2470994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells.
    Chen JW; Lin FY; Chen YH; Wu TC; Chen YL; Lin SJ
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2075-81. PubMed ID: 15374848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes.
    Wang R; Miura T; Harada N; Kametani R; Shibuya M; Fukagawa Y; Kawamura S; Ikeda Y; Hara M; Matsuzaki M
    J Pharmacol Exp Ther; 2006 Jul; 318(1):45-52. PubMed ID: 16611853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
    Fujio H; Nakamura K; Matsubara H; Kusano KF; Miyaji K; Nagase S; Ikeda T; Ogawa A; Ohta-Ogo K; Miura D; Miura A; Miyazaki M; Date H; Ohe T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):250-5. PubMed ID: 16495763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol, a multiple-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells.
    Sung CP; Arleth AJ; Eichman C; Truneh A; Ohlstein EH
    J Pharmacol Exp Ther; 1997 Nov; 283(2):910-7. PubMed ID: 9353413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol inhibits basal and stimulated ACE production in human endothelial cells.
    Saijonmaa O; Nyman T; Fyhrquist F
    J Cardiovasc Pharmacol; 2004 May; 43(5):616-21. PubMed ID: 15071347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro.
    Mizuochi Y; Okajima K; Harada N; Molor-Erdene P; Uchiba M; Komura H; Tsuda T; Katsuya H
    Transl Res; 2007 Apr; 149(4):223-30. PubMed ID: 17383596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
    Christopher TA; Lopez BL; Yue TL; Feuerstein GZ; Ruffolo RR; Ma XL
    J Pharmacol Exp Ther; 1995 Apr; 273(1):64-71. PubMed ID: 7714814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol.
    Rössig L; Haendeler J; Mallat Z; Hugel B; Freyssinet JM; Tedgui A; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2000 Dec; 36(7):2081-9. PubMed ID: 11127444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.
    Wu TC; Chen YH; Leu HB; Chen YL; Lin FY; Lin SJ; Chen JW
    Free Radic Biol Med; 2007 Dec; 43(11):1508-22. PubMed ID: 17964422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.